Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Borea

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|October 15, 1988
The influence of lipophilic character on receptor binding affinity of a series of beta-carbolinesP A Borea, M C Pietrogrande, G L Biagi
The Journal of Pharmacy and Pharmacology|December 1, 1991
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brainP A Borea, K Varani, V Malaguti, et al.
European Journal of Pharmacology|September 19, 1996
Binding thermodynamics of 5-HT1A receptor ligandsA Dalpiaz, P A Borea, S Gessi, et al.
Arzneimittel-Forschung|May 1, 1997
De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptorsA Dalpiaz, S Gessi, K Varani, et al.
Life Sciences|May 13, 1999
Alpha2-adrenergic agonist modulation of [35S]GTPgammaS binding to guanine-nucleotide-binding-proteins in human platelet membranesS Gessi, F Campi, K Varani, et al.
Arzneimittel-Forschung|January 1, 1980
Quantitative structure-activity relationship in 1-substituted ureidophenoxy-3-amino-2-propanols, a class of beta-adrenergic blocking agentsP A Borea, A Bonora, V Bertolasi, et al.
British Journal of Pharmacology|April 1, 1996
Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 bindingK Varani, S Gessi, A Dalpiaz, et al.
European Journal of Pharmacology|February 26, 1991
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brainM Trampus, E Ongini, K Varani, et al.
Il Farmaco; Edizione Scientifica|June 1, 1983
Brain receptor binding of analogues of gamma-aminobutyric acid (GABA)P A Borea, A Bonora, P G Baraldi, et al.
Il Farmaco; Edizione Scientifica|July 1, 1983
Opioid peptides. Pharmacological activity and lipophilic character of dermorphin oligopeptides. IVP A Borea, G P Sarto, S Salvadori, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|October 15, 1988
The influence of lipophilic character on receptor binding affinity of a series of beta-carbolinesP A Borea, M C Pietrogrande, G L Biagi
The Journal of Pharmacy and Pharmacology|December 1, 1991
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brainP A Borea, K Varani, V Malaguti, et al.
European Journal of Pharmacology|September 19, 1996
Binding thermodynamics of 5-HT1A receptor ligandsA Dalpiaz, P A Borea, S Gessi, et al.
Arzneimittel-Forschung|May 1, 1997
De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptorsA Dalpiaz, S Gessi, K Varani, et al.
Life Sciences|May 13, 1999
Alpha2-adrenergic agonist modulation of [35S]GTPgammaS binding to guanine-nucleotide-binding-proteins in human platelet membranesS Gessi, F Campi, K Varani, et al.
Arzneimittel-Forschung|January 1, 1980
Quantitative structure-activity relationship in 1-substituted ureidophenoxy-3-amino-2-propanols, a class of beta-adrenergic blocking agentsP A Borea, A Bonora, V Bertolasi, et al.
British Journal of Pharmacology|April 1, 1996
Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 bindingK Varani, S Gessi, A Dalpiaz, et al.
European Journal of Pharmacology|February 26, 1991
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brainM Trampus, E Ongini, K Varani, et al.
Il Farmaco; Edizione Scientifica|June 1, 1983
Brain receptor binding of analogues of gamma-aminobutyric acid (GABA)P A Borea, A Bonora, P G Baraldi, et al.
Il Farmaco; Edizione Scientifica|July 1, 1983
Opioid peptides. Pharmacological activity and lipophilic character of dermorphin oligopeptides. IVP A Borea, G P Sarto, S Salvadori, et al.
Pageof 13